Compare SHINGRIX Vaccine Response Rates
1 clinical trials · Condition
◉ Watch Compare SHINGRIX Vaccine Response Rates
| Record | Firm | Date |
|---|---|---|
| Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I) (NCT03702231) | National Heart, Lung, and Blood Institute (NHLBI) | 2018-12-07 |
Track Compare SHINGRIX Vaccine Response Rates automatically
Every clearance here is in the API, with alerts when new ones post.